Invesaro

Stocks HLI Financial statements

Financial statements

HOULIHAN LOKEY, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data HOULIHAN LOKEY, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue8729631,0841,1591,5252,2701,8091,9142,3892,618
Gross profit241278306323521795557571772
Operating expenses6907498659301,1171,6571,4681,5411,8872,090
Operating income182214219230408613342373503527
Other non-operating income-3.513.425.226.051.07-8.93-17.717.328.835.2
Pre-tax income178218224236409604324391531562
Income tax70.145.665.251.996.516669.8110132138
Net income to minority interests00000.57000-1.52
Net income108172159184313438254280400426
EBITDA191222234247423661400402544570
EPS, basic1.772.762.562.964.756.744.014.366.086.40
EPS, diluted1.632.602.422.804.556.413.764.115.826.22
Shares, basic (weighted)61.162.562.262.265.86563.464.365.766.5
Shares, diluted (weighted)66.666.365.865.768.768.367.668.268.768.4
Dividend per share0.30

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents3002072863808478347147219711,189
Property, plant and equipment30.432.13142.446.452.288.3137149143
Lease right-of-use assets0135152172334344363407
Goodwill5195295956186711,0701,0881,1271,2851,396
Total assets1,3861,4241,4261,6772,4262,8872,9693,1713,8204,309
Deferred revenue3.6227.826.827.928.840.733.148.2
Total liabilities6555665356931,0431,4431,3561,3341,6451,856
Total debt32.611.931.236.755.9
Paid-in capital855753645650804565643740843746
Retained earnings87.42072763776009221,0331,1631,3951,645
Treasury stock-194-93.500
Other comprehensive income-21.9-14-30.3-43.1-20.2-43.3-62.8-66.6-63.3-49
Shareholders' equity2,1752,342
Total equity7278538919841,3841,4441,6131,8372,1752,342
Total liabilities and equity1,3861,4191,4261,6772,4262,8872,9693,1713,8204,309

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income108172159184313438254280400424
Depreciation and amortization8.857.9114.517.315.248.558.228.541.342.6
Stock-based compensation39.447.156.664.362.491.9157167168201
Deferred income tax-6.09-6.57-10.7-9.65-21.2-71.1-3.4520.5-0.96-25.1
Change in receivables-5.53-18.221.6-13.4-3314.1-37.7-23.8-55.732.6
Change in payables13.50.3911.5-8.710.54-9.96-32-30.71.71-27.9
Cash from operations252251224288580737136328849704
Capital expenditures-14.4-7.72-6.73-20.7-14.1-8.68-50.7-66.7-39.7-22.3
Acquisitions-3.73-2.7-71.4-2.2-12.5-361-20.4-3.86-69.2-2.54
Purchases of investments0-209-147-351-392-102-19.2-11.3-250-263
Sales and maturities of investments0023134131819787.411.594.3290
Cash from investing-1.65-2196.46-33.1-99.7-274-3-70.4-2652.18
Stock issued19493.50018900
Share buybacks0-18.1-69.6-29.6-102-305-48.7-25-52.5-175
Dividends paid-55.3-52.1-66.9-80.7-92-115-140-148-165-174
Cash from financing80.2-225-236-152-26.8-459-240-251-329-493
Exchange rate effect-4.020.79-8.7-7.7613.2-16.8-12.1-0.43-0.764.93
Net change in cash327-192-14.194.6466-13.2-1197.04254218
Free cash flow23824321826756672885.5262809682
Interest paid1.620.660.981.050.9915.90.581.36
Income taxes paid57.347.680.873.944.224215710593.3187

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $129.07 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Operating margin20.4%Operating income / revenue.
EBITDA margin21.8%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin21.8%Pre-tax income / revenue.
Net margin16.1%Net income / revenue.
FCF margin19.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin19.8%Cash from operations / revenue.
Effective tax rate26.5%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)18.0%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)10.9%Net income / average total assets.
Return on invested capital (ROIC)25.1%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue8.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.6%Capital expenditures / revenue.
D&A / revenue1.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y9.5%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y13.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y11.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y4.9%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y15.5%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y5.2%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y4.7%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y12.5%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y6.1%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y6.5%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y18.7%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y6.4%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y6.9%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y18.3%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y6.5%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-17.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y72.9%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y4.0%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-15.7%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y99.8%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y3.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y7.7%Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y12.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y13.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y12.2%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Liabilities / assets36.4%Total liabilities / total assets.
Goodwill and intangibles / assets37.6%(Goodwill + intangible assets) / total assets.
Tangible book value$859.0MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.68xRevenue / average total assets.
Fixed asset turnover17.6xRevenue / average property, plant and equipment.
FCF conversion119.5%Free cash flow / net income, when net income is positive.
Capex / operating cash flow3.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$6.00Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$37.33Revenue / diluted weighted shares.
FCF per share$7.17Free cash flow / diluted weighted shares.
Operating cash flow per share$7.40Cash from operations / diluted weighted shares.
Book value per share$33.36Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$12.71Tangible book value / shares outstanding.
Cash per share$11.02(Cash + short-term investments) / shares outstanding.
Payout ratio44.9%Dividends paid / net income, when net income is positive.
Dividends / FCF37.5%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$9.02BShare price x shares outstanding.
Enterprise value$8.28BMarket cap + total debt - cash - short-term investments.
P/E22.2xMarket cap / net income. Only when net income is positive.
P/S3.57xMarket cap / revenue.
P/B4.00xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book10.5xMarket cap / tangible book value, when positive.
P/FCF18.6xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF18.0xMarket cap / cash from operations, when positive.
EV/Sales3.28xEnterprise value / revenue.
EV/EBIT16.1xEnterprise value / operating income, when both are positive.
EV/EBITDA15.1xEnterprise value / EBITDA, when both are positive.
EV/FCF17.1xEnterprise value / free cash flow, when both are positive.
FCF yield5.4%Free cash flow / market cap.
Earnings yield4.5%Net income / market cap (the inverse of P/E).
Dividend yield2.0%Dividends paid over the period / market cap.
Shareholder yield2.0%(Dividends paid + share buybacks) / market cap.
PEG1.22xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was HOULIHAN LOKEY, INC.'s revenue in fiscal 2026?

HOULIHAN LOKEY, INC. reported revenue of $2.62B for fiscal 2026, 9.5% higher than the year before.

Was HOULIHAN LOKEY, INC. profitable in fiscal 2026?

Yes. Net income was $425.7M, a net margin of 16.3%.

How much free cash flow did HOULIHAN LOKEY, INC. generate in fiscal 2026?

Cash from operations of $704.1M minus capital expenditures of $22.3M left free cash flow of $681.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to HOULIHAN LOKEY, INC.